Financials ConvaTec Group Plc

Equities

CTEC

GB00BD3VFW73

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 11:35:21 2024-05-03 am EDT 5-day change 1st Jan Change
258.8 GBX +3.77% Intraday chart for ConvaTec Group Plc +0.39% +5.98%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,213 5,446 5,258 5,748 6,337 6,648 - -
Enterprise Value (EV) 1 6,402 6,437 6,139 6,816 7,467 7,724 7,532 7,297
P/E ratio - 48.6 x 45.1 x 90.8 x 49.3 x 32.8 x 26.1 x 21.6 x
Yield 2.17% 2.09% 2.25% 2.15% 2% 2% 2.17% 2.34%
Capitalization / Revenue 2.85 x 2.88 x 2.58 x 2.77 x 2.96 x 2.94 x 2.77 x 2.6 x
EV / Revenue 3.5 x 3.4 x 3.01 x 3.29 x 3.49 x 3.42 x 3.14 x 2.85 x
EV / EBITDA 14.4 x 14.5 x 13.2 x 13.6 x 14.2 x 13.4 x 11.8 x 10.3 x
EV / FCF 18.8 x 20.5 x 29 x 49.6 x 29.2 x 27 x 22.6 x 18.6 x
FCF Yield 5.32% 4.87% 3.45% 2.02% 3.42% 3.7% 4.42% 5.37%
Price to Book 3.34 x 3.26 x 3.1 x 3.54 x 3.76 x 3.64 x 3.4 x 3.21 x
Nbr of stocks (in thousands) 1,980,983 1,999,499 2,012,171 2,043,129 2,038,814 2,046,697 - -
Reference price 2 2.631 2.724 2.613 2.813 3.108 3.248 3.248 3.248
Announcement Date 2/28/20 3/5/21 3/8/22 3/9/23 3/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,827 1,894 2,038 2,072 2,142 2,261 2,397 2,558
EBITDA 1 443.1 445 464.2 500 527.1 575.1 636.7 706.8
EBIT 1 354.3 350.2 361.7 403.7 431.8 488.8 548.3 611.4
Operating Margin 19.39% 18.49% 17.75% 19.48% 20.15% 21.62% 22.87% 23.9%
Earnings before Tax (EBT) 1 18.9 174.7 151.3 81.9 167.4 267.7 326.9 397.2
Net income 1 9.8 112.5 117.6 62.9 130.3 199.5 249.5 308.1
Net margin 0.54% 5.94% 5.77% 3.03% 6.08% 8.82% 10.41% 12.04%
EPS 2 - 0.0560 0.0580 0.0310 0.0630 0.0989 0.1243 0.1500
Free Cash Flow 1 340.4 313.3 211.8 137.5 255.3 286.1 332.8 392
FCF margin 18.63% 16.54% 10.39% 6.63% 11.92% 12.65% 13.88% 15.32%
FCF Conversion (EBITDA) 76.82% 70.4% 45.63% 27.5% 48.43% 49.75% 52.27% 55.46%
FCF Conversion (Net income) 3,473.47% 278.49% 180.1% 218.6% 195.93% 143.38% 133.38% 127.24%
Dividend per Share 2 0.0570 0.0570 0.0587 0.0605 0.0623 0.0648 0.0704 0.0761
Announcement Date 2/28/20 3/5/21 3/8/22 3/9/23 3/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q3 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 S2 2023 S1 2023 S2
Net sales 1 938.3 908 986.3 1,008 511 519.3 1,030 522.2 522.2 1,044 1,028 1,056 1,087
EBITDA - - 221.6 - - - 211.3 - - - 248.3 - -
EBIT 189.1 181.8 168.4 204 - - 157.7 - - 204.3 199.4 214.1 217.7
Operating Margin 20.15% 20.02% 17.07% 20.24% - - 15.31% - - 19.56% 19.4% 20.28% 20.03%
Earnings before Tax (EBT) -42.4 - - - - - - - - - 35.8 - -
Net income -34.7 59.1 53.4 85.8 - - 31.8 - - 48.3 14.6 55.7 -
Net margin -3.7% 6.51% 5.41% 8.51% - - 3.09% - - 4.62% 1.42% 5.28% -
EPS -0.0200 0.0300 0.0260 0.0420 - - 0.0160 - - 0.0240 0.007000 0.0270 -
Dividend per Share 0.0398 - - - - - 0.0415 - - - 0.0433 - -
Announcement Date 2/28/20 8/6/20 3/5/21 7/30/21 12/8/21 3/8/22 3/8/22 5/4/22 8/4/22 8/4/22 3/9/23 8/2/23 3/6/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,189 991 881 1,068 1,129 1,076 885 649
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.683 x 2.227 x 1.898 x 2.136 x 2.142 x 1.871 x 1.389 x 0.9186 x
Free Cash Flow 1 340 313 212 138 255 286 333 392
ROE (net income / shareholders' equity) 14.6% 14.9% 15.6% 15.5% 16.6% 17.2% 18.8% 21%
ROA (Net income/ Total Assets) 6.38% 6.52% 7.07% 7.07% 7.5% 6.23% 6.96% 8.45%
Assets 1 153.6 1,725 1,664 889.9 1,736 3,204 3,587 3,646
Book Value Per Share 2 0.7900 0.8300 0.8400 0.8000 0.8300 0.8900 0.9600 1.010
Cash Flow per Share 2 0.2000 0.2000 0.1500 0.1400 0.1900 0.2200 0.2500 0.2700
Capex 1 61.4 86.2 94.1 144 129 129 127 132
Capex / Sales 3.36% 4.55% 4.62% 6.96% 6.03% 5.69% 5.32% 5.18%
Announcement Date 2/28/20 3/5/21 3/8/22 3/9/23 3/6/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
3.248 USD
Average target price
3.956 USD
Spread / Average Target
+21.79%
Consensus
  1. Stock Market
  2. Equities
  3. CTEC Stock
  4. Financials ConvaTec Group Plc